Kane Biotech Inc Share Price Other OTC
Equities
CA4838091094
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 2.67M 1.94M 162M | Sales 2023 | 149K 108K 9.06M | Capitalization | 10.55M 7.67M 642M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.18M -182M | Net income 2023 | -5M -3.64M -304M | EV / Sales 2022 | 6.37 x |
Net Debt 2022 | 5.76M 4.19M 350M | Net Debt 2023 | 8.51M 6.19M 518M | EV / Sales 2023 | 128 x |
P/E ratio 2022 |
-2.79
x | P/E ratio 2023 |
-2.02
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.07% |
Latest transcript on Kane Biotech Inc
Managers | Title | Age | Since |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 02/16/02 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 05/17/05 |
Gregory Schultz
CTO | Chief Tech/Sci/R&D Officer | 73 | 05/22/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 15/10/15 |
Chairman | 59 | 20/02 | |
Georges Morin
BRD | Director/Board Member | - | 20/20/20 |
1st Jan change | Capi. | |
---|---|---|
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |